The effect of sphingolipids as a new therapeutic option for acne treatment

Acne and its Therapy

Volumn , Issue , 2007, Pages 155-165

  Klee, Saskia K ^a   Farwick, Mike ^a   Lersch, Peter ^a  

^a EVONIK INDUSTRIES AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85030621929     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (44)

1. Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther 2004; 17(suppl 1):43–48.
2. Van Hoogendalem EJ. Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data. J Eur Acad Dermatol Venereo 1998; 11(suppl 1):13–19; discussion 28–29.
3. Wertz PW, Swartzendruber DC, Madison KC, Downing DT. Composition and morphology of epidermal cyst lipids. J Invest Dermatol 1987; 89:419–425.
4. Williams ML, Elias PM. The extracellular matrix of stratum corneum: role of lipids in normal and pathological function. Rev Ther Drug Carrier Syst 1987; 3:95–122.
5. Thiboutot D, Knaggs H, Gilliland K, et al. Activity of 5-alpha-reductase and 17-beta-hydroxysteroid dehydrogenase in the infrainfundibulum of subjects with and without acne vulgaris. Dermatology 1998; 196:38–42.
6. Clark SM, Goulden V, Finlay AY, et al. The psychological and social impact of acne: a comparison study using three acne disability questionnaires (Abstract). Br J Dermatol 1997; 137(suppl 50):41.
7. Gupta MA, Johnson AM, Gupta AK. The development of an acne quality of life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol 1998 (Stockhausen); 78:451–456.
8. Kligman AM. An overview of acne. J Invest Dermatol 1974; 62:268–287.
9. White GM. Recent findings in the epidemiology, classification and subtypes of acne vulgaris. J Am Acad Dermatol 1998; 39:534–537.
10. Schmidt JB, Spona J, Huber J. Androgen receptor in hirsutism and acne. Gynecol Obstet Invest 1986; 22:206–211.
11. Henze C, Hinney B, Wuttke W. Incidence of increased androgen levels in patients suffering from acne. Dermatology 1998; 196:53–54.
12. Cunliffe WJ, Gollnick H. Acne diagnosis and management. In: Martin Dunitz. London: Taylor & Francis Group, 2001.
13. Zouboulis CC. Human skin: an independent peripheral endocrine organ. Horm Res 2000; 54:230–242.
14. Plewig G, Kligman AM. Acne and Rosacea. 3rd Completely Revised and Enlarged ed. Berlin: Springer-Verlag, 2000:581–582.
15. Gollnick HP, Zouboulis CC, Akamatsu H, et al. Pathogenesis and pathogenesis related treatment of acne. J Dermatol 1991; 18:489–499.
16. Knaggs HE, Holland DB, Morris C, et al. Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67. J Invest Dermatol 1994; 102:89–92.
17. Thiboutot DM, Knaggs H, Gilliland K, et al. Activity of type I 5-alpha-reductase is greater in the follicular infundibulum compared with the epidermis. Br J Dermatol 1997; 136:166–171.
18. Zouboulis CC, Xia L, Akamatsu H, et al. The human sebocyte culture model provides new insight into development and management of seborrhoea and acne. Dermatology 1998; 196:21–31.
19. Holland KT, Greenman J, Cunliffe WJ. Growth of cutaneous propionibacteria on synthetic medium: growth yields and enzyme production. J Appl Bacteriol 1979; 47:383–394.
20. Shalita AR, Lee WL. Inflammatory acne. Dermatol Clin 1983; 1:361–364.
21. Melnik B, Plewig G. New biochemical aspects of lipids in the pathogenesis of abnormal follicular keratinisation in acne vulgaris (Article in German). Z Hautkr 1988; 63:591–596.
22. Fujie T, Shikiji T, Uchida N, et al. Culture of cells derived from the human sebaceous gland under serum-free conditions without a biological feeder layer or specific matices. Arch Dermatol Res 1996; 288:703–708.
23. http://www.medizininfo.de/hautundhaar (accessed April 2005).
24. Jansen T, Burgdorf W, Plewig G. Pathogenesis and treatment of acne in childhood. Pediatr Dermatol 1997; 14:7–21.
25. Humbert P. Induced Acne (Article in French). Rev Prat 2002; 52:838–840.
26. Friedman GD. Twin studies of disease heritage based on medical records: application to acne vulgaris. Acta Genet Med Gemellol 1984; 33:487–495.
27. Gollnick H. Current concepts of the pathogenesis of acne. Drugs 2003; 63:1579–1596.
28. Törmä H. Interaction of isotretinoin with endogenous retinoids. J Am Acad Dermatol 2001; 45(suppl 5):143–149.
29. White GM. Acne therapy. Dis Mon 1999; 45:301–330.
30. Zander E, Weisman S. Treatment of acne vulgaris with salicylic acid. Clin Ther 1992; 14:247–253.
31. Zouboulis CC. Exploration of retinoid activity and the role of inflammation in acne: issues affecting the future directions for acne therapy. J Eur Acad Dermatol Venereol 2001; 15(suppl 3):63–67.
32. Müller-Bohn T. Neue Chancen in der Dermatologie. Deutsche Apotheker Zeitung 2004; 144:1967–1974.
33. Vega B, Ferret C, Jomard A, et al. Regulation of Toll-like receptor 2 expression by adapalene: implications for the treatment of inflammatory acne. Poster P0156, International Investigative Dermatology Meeting, Miami Beach, FL, April 30–May 4, 2003.
34. Elias PM. Structural lipids, barrier function, and desquamation. J Invest Dermatol 1983; 80:44s–49s.
35. Harris IR, Farrell AM, Grunfeld C, Holleran WM, Elias PM, Feingold KR. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. J Invest Dermatol 1997; 109(6):783–787.
36. Geilen CC, Wieder T, Orfanos CE. Ceramide signalling: regulatory role in cell proliferation, differentiation and apoptosis in human epidermis. Arch Dermatol Res 1997; 289(10):559–566.
37. Shapiro D, Segal K. The synthesis of sphingosine. J Am Chem Soc 1954; 76: 5896–5895.
38. van den Berg RJBH, Korevaar CGN, Overkleeft HS, et al. Effective, high-yield, and stereospecific total synthesis of D-erythro-(2R,3S)-sphingosine from D-ribo-(2S,3S,4R)-phytosphingosine. J Org Chem 2004; 69:5699–5704.
39. Inhibition of bacterial growth by phytosphingosine: An in-vitro antimicrobial study, Degussa AG (unpublished data).
40. Bibel, DJ, Aly, R, Shienfield, HR. Antimicrobial activity of sphingosines. J Invest Dermatol 2000; 98(3):269–273.
41. DNA-Chip analysis of changes in the gene expression patterns of keratinocytes after incubation with phytosphingosine, Degussa AG (unpublished data).
42. Influence on the application of phytosphingosine on reconstituted epidermis, Degussa AG (unpublished data).
43. Analysis of changes in the lipid composition of keratinocytes after incubation with phytosphingosine, Degussa AG (unpublished data).
44. Phytosphingosine clinical study on acne: determination of the effectiveness of phytosphingosine to enhance or complement existing acne therapies, Degussa AG (unpub-lished data).